| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | Inquire | Inquire | 1 | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT45322WQ is a type of small interfering RNA (siRNA) that targets KIAA0319L gene and regulates the expression of gene. The siRNA interferes with the expression of KIAA0319L gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It The product SIRGT45322WQ is a type of small interfering RNA (siRNA) that targets KIAA0319L gene and regulates the expression of gene. The siRNA interferes with the expression of KIAA0319L gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Blautia is a genus of anaerobic bacteria with probiotic characteristics that occur widely in the feces and intestines of mammals. | Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from Cynomolgus monkeys Stomach Tissue. The sample is negative for Herpes-B Virus, as well as SRV, SIV, STLV-1, and can be used for a variety of tests and Cynomolgus monkey is widely used in medical experiments, especially those associated with neuroscience and disease. This product is isolated from Cynomolgus monkeys Stomach Tissue. The sample is negative for Herpes-B Virus, as well as SRV, SIV, STLV-1, and can be used for a variety of tests and assays such as PCR, Western blot, immunoprecipitation, immunofluorescent flow cytometry.... Read More | Recombinant Ebola Virus-like Particles (EBOV VLPs) are produced in mammalian HEK293 human cells, assembled with Nucleoprotein, Glycoprotein and Matrix protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material Recombinant Ebola Virus-like Particles (EBOV VLPs) are produced in mammalian HEK293 human cells, assembled with Nucleoprotein, Glycoprotein and Matrix protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. EBOV VLPs can be used in the development of EBOV diagnostics and in vaccine development and R&D (including use as an immunogen).... Read More | The product SIRGT73619WQ-2MOE is a type of small interfering RNA (siRNA) that targets PET100 gene and regulates the expression of gene. The siRNA interferes with the expression of PET100 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The The product SIRGT73619WQ-2MOE is a type of small interfering RNA (siRNA) that targets PET100 gene and regulates the expression of gene. The siRNA interferes with the expression of PET100 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |